Literature DB >> 2592979

Immunochemical study of connectin (titin) in neuromuscular diseases using a monoclonal antibody: connectin is degraded extensively in Duchenne muscular dystrophy.

K Matsumura1, T Shimizu, I Nonaka, T Mannen.   

Abstract

Connectin (also called titin) is a myofibrillar elastic filament which links a thick filament to a neighbouring Z line in a sarcomere and thus contributes significantly to the elastic property of myofibrils. In the present study, the degradation state of connectin in biopsied skeletal muscles from various neuromuscular diseases was investigated by Western blot analysis using a monoclonal antibody which reacts extensively with the degradation products of connectin. In Duchenne muscular dystrophy (DMD), connectin was degraded progressively and relentlessly after 5 years of age. In Becker muscular dystrophy, degradation of connectin was much less than in DMD. Connectin was well preserved in normal controls, and was only minimally degraded in Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, limb girdle muscular dystrophy and myotonic dystrophy, even when the biopsied muscles showed a similar degree of weakness as those of DMD. The degradation of connectin, even though secondary, is presumed to play an important role in the pathogenesis of myofibrillar degeneration in DMD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592979     DOI: 10.1016/0022-510x(89)90185-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Effects of different enzymic treatments on the release of titin fragments from rabbit skeletal myofibrils. Purification of an 800 kDa titin polypeptide.

Authors:  C Astier; J P Labbé; C Roustan; Y Benyamin
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

2.  The distribution of desmin and titin in normal and dystrophic human muscle.

Authors:  M J Cullen; J J Fulthorpe; J B Harris
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila.

Authors:  Mario Pantoja; Karin A Fischer; Nicholas Ieronimakis; Morayma Reyes; Hannele Ruohola-Baker
Journal:  Development       Date:  2012-11-15       Impact factor: 6.868

4.  The fate of desmin and titin during the degeneration and regeneration of the soleus muscle of the rat.

Authors:  R Vater; M J Cullen; J B Harris
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts.

Authors:  Matthew S Barnabei; Joseph M Metzger
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

6.  Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy.

Authors:  Diem-Hang Nguyen-Tran; Nitai C Hait; Henrik Sperber; Junlin Qi; Karin Fischer; Nick Ieronimakis; Mario Pantoja; Aislinn Hays; Jeremy Allegood; Morayma Reyes; Sarah Spiegel; Hannele Ruohola-Baker
Journal:  Dis Model Mech       Date:  2013-09-25       Impact factor: 5.758

7.  A sandwich ELISA kit reveals marked elevation of titin N-terminal fragment levels in the urine of mdx mice.

Authors:  Taku Shirakawa; Ayumu Ikushima; Nobuhiro Maruyama; Yoshinori Nambu; Hiroyuki Awano; Kayo Osawa; Kei Nirasawa; Yoichi Negishi; Hisahide Nishio; Shoji Fukushima; Masafumi Matsuo
Journal:  Animal Model Exp Med       Date:  2022-02-03

8.  Dystrophin is not essential for the integrity of the cytoskeleton.

Authors:  R Massa; L Castellani; G Silvestri; G Sancesario; G Bernardi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy.

Authors:  Mario Pantoja; Hannele Ruohola-Baker
Journal:  Rare Dis       Date:  2013-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.